Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy
Journal of the Advanced Practitioner in Oncology · 05.05.2026 · 17 (7)
DOI: 10.6004/jadpro.2026.17.7.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 05.05.2026. Verfasst von Maria D Guerrero. Beteiligte Einrichtung: From The University of Texas MD Anderson Cancer Center, Houston, Texas. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The treatment landscape for advanced-stage Hodgkin lymphoma (HL) continues to evolve, with immune checkpoint inhibitors now pivotal to improving patient outcomes. One of the most promising developments is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This novel approach has demonstrated encouraging efficacy and is increasingly integrated into frontline treatment regimens. This article provides practical, evidence-based knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD. It reviews the most frequently observed adverse events, including immune-mediated events, and outlines best practices for monitoring and management. A real-world case study illustrates how proactive management and clinical judgment can influence outcomes in patients receiving nivolumab-AVD.
Autor:innen und Institutionen
- From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zitieren
APA
Guerrero, M. D. (2026). Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy. Journal of the Advanced Practitioner in Oncology, 17(7). https://doi.org/10.6004/jadpro.2026.17.7.15
Vancouver
Guerrero MD. Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy. Journal of the Advanced Practitioner in Oncology. 2026;17(7). doi:10.6004/jadpro.2026.17.7.15
BibTeX
@article{Guerrero2026,
author = {Guerrero, Maria D},
title = {Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy},
journal = {Journal of the Advanced Practitioner in Oncology},
year = {2026},
volume = {17},
number = {7},
doi = {10.6004/jadpro.2026.17.7.15}
}
EUVIMED